Histologics

Histologics

Is this your company? Claim your profile to update info and connect with investors.
Claim profile

Private Company

Funding information not available

Overview

Histologics is a private medical device company developing innovative, patient-friendly tools for cervical biopsy and endocervical curettage. Its proprietary Kylon® fabric technology enables a gentler, trans-epithelial biopsy technique aimed at reducing patient discomfort and improving specimen quality during colposcopy procedures. The company's commercial product portfolio includes the SoftBiopsy®, Soft ECC®, Soft ECC-S®, and Spirabrush® devices, which are marketed directly to gynecologists and colposcopy clinics. Founded in 2016 and headquartered in San Diego, Histologics operates in the diagnostics sector with a focus on improving the standard of care in cervical cancer prevention.

Women's HealthOncology Diagnostics

Technology Platform

Kylon® - a patented micro-hook fabric for gentle, frictional de-bonding and capture of epithelial tissue for biopsy.

Opportunities

The primary opportunity is displacing traditional, painful metal biopsy tools in the global colposcopy market by offering a superior patient experience without compromising diagnostic yield.
Secondary opportunities include expanding the Kylon® platform into adjacent high-volume markets like wound debridement and veterinary medicine, leveraging the same core technology for gentle tissue removal.

Risk Factors

Key risks include slow clinician adoption due to entrenched use of traditional tools, challenges in securing favorable insurance reimbursement codes, and potential competition from larger medical device companies with greater resources.
Regulatory compliance and manufacturing scalability for a novel fabric-based device also present ongoing execution risks.

Competitive Landscape

Histologics competes directly with manufacturers of standard metal punch biopsy forceps (e.g., Kevorkian, Tischler) and endocervical curettes, which are low-cost and widely familiar. It also competes with other cervical sampling devices like cytobrushes (for cytology, not histology). Its differentiation is based on patient comfort and a unique tissue-capture mechanism, but it must overcome the significant inertia of established clinical practice.